share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 7 06:40
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月7日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。該公司在2023年12月19日至2024年2月7日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年2月7日，當日購回1,000,000股普通股，佔已發行股份的0.0957%，每股價格介乎HKD 1.59至HKD 1.71，總付出金額為HKD 1,643,240。自普通決議案通過以來，公司累計在香港聯交所購回66,121,000股，佔當時已發行股份的6.0821%。公司確認，所有購回活動均獲董事會批准，並符合相關上市規則。
歌禮製藥有限公司於2024年2月7日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。該公司在2023年12月19日至2024年2月7日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年2月7日，當日購回1,000,000股普通股，佔已發行股份的0.0957%，每股價格介乎HKD 1.59至HKD 1.71，總付出金額為HKD 1,643,240。自普通決議案通過以來，公司累計在香港聯交所購回66,121,000股，佔當時已發行股份的6.0821%。公司確認，所有購回活動均獲董事會批准，並符合相關上市規則。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 7 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. The company conducted several share repurchases between December 19, 2023 and February 7, 2024, but did not write them off. The most recent repurchase took place on 7 February 2024 and repurchased 1,000,000 shares of ordinary shares representing 0.0957% of the issued shares at a price of HKD 1.59 to HKD 1.71 per share for a total payment of HKD 1,643,240. Since the adoption of the Ordinary Resolution, the Company has collectively repurchased 66,121,000 shares on the Hong Kong Stock Exchange, representing 6.0821% of the shares issued at the time. The Company confirms that all repurchases have been approved by the Board of Directors and are in compliance with the relevant listing rules.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 7 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. The company conducted several share repurchases between December 19, 2023 and February 7, 2024, but did not write them off. The most recent repurchase took place on 7 February 2024 and repurchased 1,000,000 shares of ordinary shares representing 0.0957% of the issued shares at a price of HKD 1.59 to HKD 1.71 per share for a total payment of HKD 1,643,240. Since the adoption of the Ordinary Resolution, the Company has collectively repurchased 66,121,000 shares on the Hong Kong Stock Exchange, representing 6.0821% of the shares issued at the time. The Company confirms that all repurchases have been approved by the Board of Directors and are in compliance with the relevant listing rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more